Josh Riggs

Insider Reports History

Location
Irvine, CA
Signature
/s/ Josh Riggs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Josh Riggs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Insight Molecular Diagnostics Inc. CEO and President, Director Restricted Stock Units 141,509 $386,792 $2.05 26 Mar 2026 Direct
Insight Molecular Diagnostics Inc. CEO and President, Director Common Stock 38,365 $287,737 $7.50 26 Mar 2026 Direct
Insight Molecular Diagnostics Inc. CEO and President, Director Option to Purchase Common Stock 400,000 28 Sep 2025 Direct

Insider Reports Filed by Josh Riggs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMDX Insight Molecular Diagnostics Inc. 26 Mar 2026 3 $0 4 CEO and President, Director 30 Mar 2026, 17:29
OCX Insight Molecular Diagnostics Inc. 28 Sep 2025 1 $0 4 CEO and President, Director 30 Sep 2025, 16:05
OCX Oncocyte Corp 26 Mar 2025 1 $0 4 CEO and President 28 Mar 2025, 16:05
OCX Oncocyte Corp 20 May 2024 1 $0 4 CEO and President, Director 22 May 2024, 16:56
OCX Oncocyte Corp 11 Apr 2024 1 +$10,000 4 CEO and President, Director 15 Apr 2024, 06:04
OCX Oncocyte Corp 15 Aug 2023 1 $0 4 CEO and President, Director 17 Aug 2023, 18:57
OCX Oncocyte Corp 09 Jun 2023 2 $0 4 CEO and President, Director 13 Jun 2023, 16:05
OCX Oncocyte Corp 24 Feb 2023 1 $0 4 CEO 28 Feb 2023, 16:59
OCX Oncocyte Corp 17 Jan 2023 1 $0 4 Interim CEO 19 Jan 2023, 16:18
OCX Oncocyte Corp 02 Dec 2022 0 $0 3 Interim CEO 09 Dec 2022, 19:19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .